The challenge of the lantibiotics: synthetic approaches to thioether-bridged peptides.
about
Variable characteristics of bacteriocin-producing Streptococcus salivarius strains isolated from Malaysian subjectsLanthipeptides: chemical synthesis versus in vivo biosynthesis as tools for pharmaceutical productionIn vitro selection of functional lantipeptides.Decarbonylative approach to the synthesis of enamides from amino acids: stereoselective synthesis of the (Z)-aminovinyl-D-cysteine unit of mersacidinPhosphoserine Lyase Deoxyribozymes: DNA-Catalyzed Formation of Dehydroalanine Residues in Peptides.Chemical synthesis and biological activity of analogues of the lantibiotic epilancin 15X.Chemical synthesis of the lantibiotic lacticin 481 reveals the importance of lanthionine stereochemistry.Increasing the success rate of lantibiotic drug discovery by Synthetic Biology.Multipronged approach for engineering novel peptide analogues of existing lantibiotics.Employing the promiscuity of lantibiotic biosynthetic machineries to produce novel antimicrobials.Enhancing the therapeutic potential of peptide toxins.The Role of Disulfide Bond Replacements in Analogues of the Tarantula Toxin ProTx-II and Their Effects on Inhibition of the Voltage-Gated Sodium Ion Channel Nav1.7.Thioether analogues of disulfide-bridged cyclic peptides targeting death receptor 5: conformational analysis, dimerisation and consequences for receptor activation.Synthesis of the AviMeCys-containing D-ring of mersacidin.Novel thiol- and thioether-containing amino acids: cystathionine and homocysteine families.Scalable purification of the lantibiotic nisin and isolation of chemical/enzymatic cleavage fragments suitable for semi-synthesis.Constructing thioether-tethered cyclic peptides via on-resin intra-molecular thiol-ene reaction.Cyclization of peptides by using selenolanthionine bridges.Recent Progress in the Chemical Synthesis of Class II and S-Glycosylated Bacteriocins.Bridged bicyclic peptides as potential drug scaffolds: synthesis, structure, protein binding and stability.
P2860
Q21558804-3F7D60A9-0E38-4320-AC91-2710491C2FB8Q26748638-9775AD0B-0FE1-4923-880C-F61A58892C84Q34251682-0884328F-10A6-4F24-9608-6770B4BC4983Q35839403-5F81AE5C-2715-4B78-A8C7-8E4CE61E92FEQ35925245-4AC4344F-FB75-445B-9BFF-0DC5A900E730Q35949915-7CF19059-E3E6-4A99-A266-C23E235ABC4EQ37078724-8E649D80-0484-4712-953A-361CF07DBA1DQ38017216-EAF07173-715C-4415-9C42-4FF95B5E7CFDQ38500614-2D83A7E1-4623-427C-9CB9-68AD00B9C5D8Q38945513-651138E5-C0AF-43FC-ACDF-E255A7811C34Q39234026-40A0B6F3-545B-4C80-93E9-5F00A417BF55Q41665872-F7C1F607-0C57-40C1-B95A-DD043BE91B15Q41714576-3F230750-B568-4978-AAA8-D0BA66DBC821Q42734786-F280F81A-C6C6-4ACC-9856-18FDB0CDAD8AQ44007940-EBCD0EA6-F37C-4008-BD83-C7949ECB9C02Q46152521-8B6AAB96-D9EB-447F-824A-D9BCF6E0803AQ53862367-0639AFB1-5C2D-479F-A170-6A6EE07A3838Q54210515-5EAAB7A1-292E-44F4-98F6-E5D19F9B1051Q54959662-58FC77CB-7E2F-4815-B8A1-D23B6DF9D932Q54981966-48CFA600-1C1A-421E-918B-2EC6666DB548
P2860
The challenge of the lantibiotics: synthetic approaches to thioether-bridged peptides.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The challenge of the lantibiotics: synthetic approaches to thioether-bridged peptides.
@en
The challenge of the lantibiotics: synthetic approaches to thioether-bridged peptides.
@nl
type
label
The challenge of the lantibiotics: synthetic approaches to thioether-bridged peptides.
@en
The challenge of the lantibiotics: synthetic approaches to thioether-bridged peptides.
@nl
prefLabel
The challenge of the lantibiotics: synthetic approaches to thioether-bridged peptides.
@en
The challenge of the lantibiotics: synthetic approaches to thioether-bridged peptides.
@nl
P2860
P356
P1476
The challenge of the lantibiotics: synthetic approaches to thioether-bridged peptides.
@en
P2093
Alethea B Tabor
P2860
P304
P356
10.1039/C1OB05946G
P577
2011-09-29T00:00:00Z